Category Archives: Drugs

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Hepatitis Drugs Market 2011-2015 http://www.reportlinker.com/p01009241/Global-Hepatitis-Drugs-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication TechNavio's analysts forecast the Global Hepatitis Drugs market to grow at a CAGR of 12.42 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in demand for hepatitis drugs in developing countries. The Global Hepatitis Drugs market has also been witnessing an increase in the number of mergers and acquisitions. However, the shortage of hepatitis drugs to meet market demand could pose a challenge to the growth of this market. TechNavio's report, the Global Hepatitis Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hepatitis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include Bristol-Myers Squibb Co., Gilead Sciences Inc., GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Merck & Co. Inc. Other vendors mentioned in the report: … Continue reading →

WASHINGTON More Americans than ever are taking generic drugs, as blockbuster medicines like Plavix and Lipitor become available in low-cost versions. But the government's revelation this week that it mistakenly approved a defective generic antidepressant could stoke longtime concerns about the quality of knockoff drugs. The Food and Drug Administration on Wednesday Oct. 3 asked Teva Pharmaceuticals to withdraw its drug Budeprion XL 300 after testing showed the drug did not properly release its key ingredient. The drug is supposed to be equivalent to GlaxoSmithKline's popular antidepressant Wellbutrin XL, which is prescribed to treat depression, anxiety and symptoms of nicotine withdrawal. The announcement marked an about-face for regulators, who said in 2008 that the two drugs were essentially the same, despite hundreds of complaints from patients who said they experienced side effects such as headaches, anxiety and insomnia after switching to the generic drug. The FDA has withdrawn generic drugs before, but this appears to be the first case driven by consumer complaints, which continued to pile up after the FDA said the drug was working correctly. "The lesson is that everyone - from pharmacists to physicians to the FDA -- needs to take these reports seriously," said Dr. Tod … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/tr5tkv/chinese_markets) has announced the addition of the "Chinese Markets for Asthma Treatment Drugs" report to their offering. China's demand for asthma treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled. Companies Mentioned Beijing SL Pharmaceutical Co., Ltd Yangtze River Pharmaceutical Group Hangzhou Aoyipollen Pharmaceutical Co., Ltd. Zhuhai Union Pharmaceutical Co., Ltd Shandong Qilu Pharmaceutical Co., Ltd Chengdu Minyi Pharmaceutical Co., Ltd See more here: Research and Markets: Chinese Markets for Asthma Treatment Drugs Report Gives Long-term Forecasts through 2016 and 2021 … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/j2fpr2/chinese_markets) has announced the addition of the "Chinese Markets for Anti-infectious Disease Drugs" report to their offering. China's demand for anti-infectious disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled. Companies Mentioned Beijing SL Pharmaceutical Co., Ltd Yangtze River Pharmaceutical Group Hangzhou Aoyipollen Pharmaceutical Co., Ltd. Zhuhai Union Pharmaceutical Co., Ltd Shandong Qilu Pharmaceutical Co., Ltd Chengdu Minyi Pharmaceutical Co., Ltd Read the rest here: Research and Markets: Chinese Markets for Anti-infectious Disease Drugs - Forecasting 2012-2021 … Continue reading →

8 October 2012 Last updated at 07:08 ET A drugs operation which has seen more than 50 people charged in the Scottish Borders is entering a new phase. Operation Goal was launched in July to remove individuals involved in street-level drug dealing from communities. Officers carried out raids in Galashiels, Hawick, Melrose, Selkirk and Kelso over a six-week period. Lothian and Borders Police said that after the enforcement stage of the operation they now intended to look at "diversion and intervention". Operation Goal is a long-term project to not only minimise, but eradicate the scourge of drugs within Scottish Borders communities A total of 54 people have been charged under the Misuse of Drugs Act following the first phase of the action. Seven are now serving custodial sentences and a series of trials are expected to start at the end of the month. The second phase of the operation will see police visit schools throughout the region to discuss the consequences of becoming involved in drug crime. Joint presentations with NHS Borders and Scottish Borders Council will encourage children to ask any questions or raise any concerns about the issue. Read the original: Drugs operation enters new phase … Continue reading →

Nano-medicine - using nano-sized particles to deliver drugs - has the potential to revolutionise the treatment of common maternal and fetal conditions, without side effects or risks to the mother or baby, according to a leading researcher. Jeff Keelan, principal research fellow in the University of WA's School of Women's and Infants' Health, said nano-technology had the potential to create drugs that "boldly go where no drug has gone before". "In conventional medicine you take a pill, aspirin say, and it gets dissolved in the stomach, enters the bloodstream and circulates around the body so all of the organs and tissues in your body get exposed to that drug," he said. "It is very non-selective." Nano-medicine is a bit like adding a postcode to medications - it allows the drugs to be targeted to a specific destination in the body. Nano-particles, which are the "envelopes" that contain the drugs, are usually made out of a biodegradable polymer and are about the size of a virus, ranging from one to 200 nanometres in diameter. A nanometre is one billionth of a metre. The "envelope" or shell has a chemical structure that enables it to be targeted to a specific tissue. Once … Continue reading →

Synthetic drugs, often interchangeably known as designer drugs, spread from Europe to the U.S. as recently as 2009 and have been a growing method by which users have been getting high purportedly without getting caught, although they are caught. There are many scientific-community observations about synthetic drugs. One is that they are less dangerous than the real thing; thats absolutely false. Owned by Dayton residents, Baytown-based STAT Testing, a drug and alcohol testing firm, has executives who speak candidly about the reality of this phenomenon, experts such as Marketing, On-Sites and Mobile Services Director Heather Barlow, who know that education is one of the keys to addressing the problem. Barlow was the guest speaker at the Oct. 2 Dayton Chamber of Commerce Luncheon held at the Dayton Community Center. Police in Mont Belvieu in June arrested people who were on it; indeed three one night were jailed down there when STAT Testing personnel were doing a town hall meeting in that city. Their accounts of the mind-altering effects should alarm people into never fooling with synthetic marijuana, synthetic cocaine, known as bath salts, or any other manmade drug containing chemical compositions that produce stronger effects of the real thing. Often … Continue reading →

TRENTON, N.J. (AP) -- The Food and Drug Administration is stepping up its fight against counterfeit and other potentially harmful medicine sold over the Internet. The agency is ordering operators of about 4,100 websites to immediately stop selling unapproved medications to U.S. consumers. The move is part of a weeklong global crackdown by regulatory bodies and law enforcement on websites selling counterfeit, substandard and unapproved medicines, aimed at making the global medicine supply safer. It also follows the FDA's launch last Friday of a campaign to warn consumers that the vast majority of online pharmacies do not follow laws or pharmacy industry standards and their products could harm or even kill people. The campaign includes a new website, http://www.fda.gov/BeSafeRx , that explains the risks of fake online pharmacies and how to tell the difference between those websites and legitimate ones. The FDA has sent warning letters to three companies behind most of the 4,100 websites it identified as illegally selling potentially dangerous, unapproved drugs. It's also seized some illegal medicines, filed civil and criminal charges against companies and individuals, and contacted Internet registrars and service providers, asking them to suspend the 4,100 websites. "This is a first step," said FDA … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/qv6r8b/infertility_drugs) has announced the addition of the "Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017" report to their offering. This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives. This report highlights the industry with the following points: - Definition, estimates and forecast of infertility drugs and devices market from 2010 to 2017 - Analysis of product segments for infertility drugs and devices market with historical data and forecast - Trends and forecast for four geographic markets, namely North America, … Continue reading →

Recent fungal meningitis cases are part of a growing concern over contaminated custom-mixed drugs from 'compounding pharmacies' that supply hospitals, clinics, and doctors. The custom-mixed drugs are not FDA approved. Two people blinded in Washington, D.C., in 2005. Three dead in Virginia in 2006 and three more in Oregon the following year. Twenty-one dead polo horses in Florida in 2009. Earlier this year, 33 people in seven states with fungal eye infections. Subscribe Today to the Monitor Click Here for your FREE 30 DAYS of The Christian Science Monitor Weekly Digital Edition And now, at least five people dead and 35 diagnosed as sick with fungal meningitis that authorities say has been linked to steroid shots for back pain. All these tragedies involved medicines that had been custom-mixed at what are called "compounding pharmacies" laboratories that supply hospitals, clinics and doctors to a much wider degree in the U.S. than many people realize. These pharmacies mix solutions, creams and other medicines used to treat everything from menopause symptoms and back pain to vision loss and cancer. Unlike manufactured drugs, these products are not subject to approval by the Food and Drug Administration. And some have turned out to be dangerously … Continue reading →